Publications 2014

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

Taieb J, Tabernero J, Mini E, Subtil F, Folprecht G, van Laethem J, Thaler J, Bridgewater J, Norgard Peterson L, Blons H, Collette L, van Cutsen E, Rougier P, Salazar R, Bedenne L, Emile J, Laurent-Puig P, Lepage C

The Lancet Oncology
Early Online Publication June 11, 2014

Download publication


The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer

Filipits M, Nielsen T, Rudas M, Greil R, Stöger H, Jakesz R, Bago-Horvath Z, Dietze O, Regitnig P, Gruber-Rossipal C, Müller-Holzner E, Singer C, Mlineritsch B, Dubsky P, Bauernhofer T, Hubalek M, Knauer M, Trapl H, Fesl C, Schaper C, Ferree S, Liu S, Cowens J, Gnant M, for the Austrian Breast and Colorectal Cancer Study Group

Clinical Cancer Research
Published OnlineFirst February 11, 2014

Download publication